Literature DB >> 24366221

The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.

Lesley Ann Saketkoo1, Jeanette H Magnus, Mittie K Doyle.   

Abstract

Systemic sclerosis (SSc) is a disease of unknown causative factor that manifests as a heterogenous group of multiorgan system manifestations and is characterized by vasculopathy and fibrosis of the skin and internal organs, with mortality related to pulmonary, cardiac, renal or gastrointestinal involvement. The prevalence of SSc may be underestimated in the general population. Cases are often undiagnosed or misdiagnosed, particularly cases with mild or no skin manifestations. Because of late referrals to rheumatologic care, many moderate-to-severe cases progress to irreversible end-organ damage that might have been prevented by early diagnosis. Early diagnosis of SSc with initiation of appropriate treatment is essential, with great impact on morbidity and mortality. This review examines presenting features, ensuing complications and treatment providing a focus on SSc as a treatable disease. Primary care providers play a pivotal role in recognizing initial symptoms associated with SSc and securing early diagnosis through early referral to specialists.

Entities:  

Mesh:

Year:  2014        PMID: 24366221      PMCID: PMC3872337          DOI: 10.1097/MAJ.0b013e3182a55d24

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  93 in total

1.  Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features.

Authors:  B Ranque; A Bérezné; V Le-Guern; C Pagnoux; Y Allanore; D Launay; E Hachulla; F-J Authier; R Gherardi; A Kahan; J Cabane; L Guillevin; L Mouthon
Journal:  Scand J Rheumatol       Date:  2010-08-20       Impact factor: 3.641

2.  Computerized nailfold video capillaroscopy--a new tool for assessment of Raynaud's phenomenon.

Authors:  Marina E Anderson; P Danny Allen; Tonia Moore; Val Hillier; Christopher J Taylor; Ariane L Herrick
Journal:  J Rheumatol       Date:  2005-05       Impact factor: 4.666

3.  Erectile failure in systemic sclerosis.

Authors:  E V Lally; S A Jimenez
Journal:  N Engl J Med       Date:  1990-05-10       Impact factor: 91.245

4.  Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells.

Authors:  Jérôme Avouac; Nicolas Cagnard; Jörg H Distler; Yoland Schoindre; Barbara Ruiz; Pierre Olivier Couraud; Georges Uzan; Catherine Boileau; Gilles Chiocchia; Yannick Allanore
Journal:  Arthritis Rheum       Date:  2011-11

5.  Esophageal involvement and pulmonary manifestations in systemic sclerosis.

Authors:  I Marie; S Dominique; H Levesque; P Ducrotté; P Denis; M F Hellot; H Courtois
Journal:  Arthritis Rheum       Date:  2001-08

6.  Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982.

Authors:  V D Steen; C V Oddis; C G Conte; J Janoski; G Z Casterline; T A Medsger
Journal:  Arthritis Rheum       Date:  1997-03

7.  Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis.

Authors:  Nicoletta Del Papa; Nadia Quirici; Cinzia Scavullo; Umberto Gianelli; Laura Corti; Claudio Vitali; Clodoveo Ferri; Dilia Giuggioli; Andreina Manfredi; Wanda Maglione; Francesco Onida; Michele Colaci; Silvano Bosari; Giorgio Lambertenghi Deliliers
Journal:  J Rheumatol       Date:  2010-08-17       Impact factor: 4.666

8.  EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Authors:  O Kowal-Bielecka; R Landewé; J Avouac; S Chwiesko; I Miniati; L Czirjak; P Clements; C Denton; D Farge; K Fligelstone; I Földvari; D E Furst; U Müller-Ladner; J Seibold; R M Silver; K Takehara; B Garay Toth; A Tyndall; G Valentini; F van den Hoogen; F Wigley; F Zulian; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2009-01-15       Impact factor: 19.103

9.  Association of myositis and myocarditis in progressive systemic sclerosis.

Authors:  S G West; P J Killian; O J Lawless
Journal:  Arthritis Rheum       Date:  1981-05

10.  Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.

Authors:  Florian M P Meier; Klaus W Frommer; Robert Dinser; Ulrich A Walker; Laszlo Czirjak; Christopher P Denton; Yannick Allanore; Oliver Distler; Gabriela Riemekasten; Gabriele Valentini; Ulf Müller-Ladner
Journal:  Ann Rheum Dis       Date:  2012-05-21       Impact factor: 19.103

View more
  6 in total

1.  Systemic Sclerosis and Perceptions of Quality in Primary Care.

Authors:  Ashley L Toci; J Madison Hyer; Richard M Silver; Paul J Nietert; Faye N Hant
Journal:  Am J Med Sci       Date:  2016-02-17       Impact factor: 2.378

2.  A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis.

Authors:  Juan Chen; Ling Lei; Jie Pan; Cheng Zhao
Journal:  Clin Rheumatol       Date:  2019-12-14       Impact factor: 2.980

Review 3.  Extrahepatic Manifestations of Primary Biliary Cholangitis.

Authors:  Sara L Chalifoux; Peter G Konyn; Gina Choi; Sammy Saab
Journal:  Gut Liver       Date:  2017-11-15       Impact factor: 4.519

4.  Demographic associations for autoantibodies in disease-free individuals of a European population.

Authors:  Kadri Haller-Kikkatalo; Kristi Alnek; Andres Metspalu; Evelin Mihailov; Kaja Metsküla; Kalle Kisand; Heti Pisarev; Andres Salumets; Raivo Uibo
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

5.  Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches.

Authors:  Paraskevi Chairta; Paschalis Nicolaou; Kleitos Sokratous; Christine Galant; Frédéric Houssiau; Anastasis Oulas; George M Spyrou; Marta E Alarcon-Riquelme; Bernard R Lauwerys; Kyproula Christodoulou
Journal:  Arthritis Res Ther       Date:  2020-05-07       Impact factor: 5.156

6.  Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis.

Authors:  Zhou Zhou; Yanni Fan; Darren Thomason; Wenxi Tang; Xinyue Liu; Zheng-Yi Zhou; Dendy Macaulay; Aryeh Fischer
Journal:  Adv Ther       Date:  2019-03-30       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.